These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure. Kissling KT, Pickworth KK. Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816 [Abstract] [Full Text] [Related]
3. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R, Ciccarelli A, Ariano C, Cioppa C, Giasi A, Pucciarelli A, Cantatrione S. Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961 [Abstract] [Full Text] [Related]
5. Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure. Trullàs JC, Morales-Rull JL, Casado J, Freitas Ramírez A, Manzano L, Formiga F, CLOROTIC investigators. J Card Fail; 2016 Jul; 22(7):529-36. PubMed ID: 26576715 [Abstract] [Full Text] [Related]
6. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S. Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669 [Abstract] [Full Text] [Related]
7. [Diuretic therapy in acute heart failure]. Trullàs JC, Morales-Rull JL, Formiga F. Med Clin (Barc); 2014 Mar; 142 Suppl 1():36-41. PubMed ID: 24930082 [Abstract] [Full Text] [Related]
8. A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension. Dussol B, Moussi-Frances J, Morange S, Somma-Delpero C, Mundler O, Berland Y. Nephrol Dial Transplant; 2005 Feb; 20(2):349-53. PubMed ID: 15615808 [Abstract] [Full Text] [Related]
9. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. Paterna S, Di Pasquale P, Parrinello G, Amato P, Cardinale A, Follone G, Giubilato A, Licata G. Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493 [Abstract] [Full Text] [Related]
10. Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure. Paterna S, Di Gaudio F, La Rocca V, Balistreri F, Greco M, Torres D, Lupo U, Rizzo G, di Pasquale P, Indelicato S, Cuttitta F, Butler J, Parrinello G. Adv Ther; 2015 Oct; 32(10):971-82. PubMed ID: 26521190 [Abstract] [Full Text] [Related]
13. Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure. Knauf H, Mutschler E. J Cardiovasc Pharmacol; 1995 Sep; 26(3):394-400. PubMed ID: 8583780 [Abstract] [Full Text] [Related]
14. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Cotter G, Weissgarten J, Metzkor E, Moshkovitz Y, Litinski I, Tavori U, Perry C, Zaidenstein R, Golik A. Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855 [Abstract] [Full Text] [Related]
15. Severe electrolyte disturbances and renal failure in elderly patients with combined diuretic therapy including xipamid. Sandhofer A, Kähler C, Heininger D, Bellmann R, Wiedermann CJ, Joannidis M. Wien Klin Wochenschr; 2002 Nov 30; 114(21-22):938-42. PubMed ID: 12528327 [Abstract] [Full Text] [Related]
17. Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial. Trullàs JC, Morales-Rull JL, Casado J, Carrera-Izquierdo M, Sánchez-Marteles M, Conde-Martel A, Dávila-Ramos MF, Llácer P, Salamanca-Bautista P, Pérez-Silvestre J, Plasín MÁ, Cerqueiro JM, Gil P, Formiga F, Manzano L, CLOROTIC trial investigators. Eur Heart J; 2023 Feb 01; 44(5):411-421. PubMed ID: 36423214 [Abstract] [Full Text] [Related]
18. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, Beckman E, Abraham WT. Circulation; 2002 Mar 19; 105(11):1348-53. PubMed ID: 11901047 [Abstract] [Full Text] [Related]
19. The efficacy and safety of furosemide and a combination of spironolactone and hydrochlorothiazide in congestive heart failure. Levy B. J Clin Pharmacol; 1977 Jul 19; 17(7):420-30. PubMed ID: 328540 [Abstract] [Full Text] [Related]
20. High-dose furosemide in the treatment of refractory congestive heart failure. Gerlag PG, van Meijel JJ. Arch Intern Med; 1988 Feb 19; 148(2):286-91. PubMed ID: 3341836 [Abstract] [Full Text] [Related] Page: [Next] [New Search]